We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
(+2.6%)
Cap. Flow
-$89M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$48.8M |
| 2 |
Procter & Gamble
PG
|
+$24.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$23.6M |
| 4 |
Keysight
KEYS
|
+$23.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
ExxonMobil
XOM
|
+$36.6M |
| 3 |
GG
Goldcorp Inc
GG
|
+$24.9M |
| 4 |
Walt Disney
DIS
|
+$23.8M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.16% |
| 2 | Technology | 16.87% |
| 3 | Financials | 10.38% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
751
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $332K | ﹤0.01% |
22,500
| – | – |
|
752
KT
KT
$8.84B
| $327K | ﹤0.01% |
26,525
+6,560
| +33% | +$79.9K |
|
753
Grupo Cibest SA
CIB
$20.4B
| $321K | ﹤0.01% |
6,314
| – | – |
|
754
Itron
ITRI
$3.73B
| $307K | ﹤0.01% |
+4,933
| New | +$274K |
|
755
Restaurant Brands International
QSR
$25.1B
| $305K | ﹤0.01% |
4,396
-628
| -13% | -$42K |
|
756
Cenovus Energy
CVE
$54.6B
| $300K | ﹤0.01% |
34,134
+1,122
| +3% | +$10.1K |
|
757
SL Green Realty
SLG
$3.88B
| $296K | ﹤0.01% |
3,818
+656
| +21% | +$55.3K |
|
758
Coty
COTY
$2.33B
| $291K | ﹤0.01% |
21,826
-18,065
| -45% | -$222K |
|
|
AUO
759
DELISTED
AU Optronics Corp
AUO
| $284K | ﹤0.01% |
96,327
| – | – |
|
760
Affiliated Managers Group
AMG
$9.46B
| $281K | ﹤0.01% |
3,060
| – | – |
|
|
MDSO
761
DELISTED
Medidata Solutions, Inc.
MDSO
| $270K | ﹤0.01% |
+3,000
| New | +$263K |
|
762
Avery Dennison
AVY
$12.3B
| $268K | ﹤0.01% |
+2,325
| New | +$254K |
|
763
Acuity Brands
AYI
$9.88B
| $265K | ﹤0.01% |
+1,930
| New | +$265K |
|
764
DaVita
DVA
$15.1B
| $251K | ﹤0.01% |
4,475
+530
| +13% | +$27.5K |
|
765
Ameresco
AMRC
$1.15B
| $242K | ﹤0.01% |
+16,513
| New | +$253K |
|
766
Travel + Leisure Co
TNL
$4.54B
| $230K | ﹤0.01% |
5,252
| – | – |
|
767
CEMIG Preferred Shares
CIG
$6.09B
| $229K | ﹤0.01% |
118,289
| – | – |
|
768
Agnico Eagle Mines
AEM
$72.6B
| $228K | ﹤0.01% |
4,460
-3,823
| -46% | -$167K |
|
769
Wyndham Hotels & Resorts
WH
$5.46B
| $218K | ﹤0.01% |
+3,926
| New | +$215K |
|
770
Weibo
WB
$1.9B
| $217K | ﹤0.01% |
5,000
-22,000
| -81% | -$1.23M |
|
771
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$258M
| $207K | ﹤0.01% |
+6,460
| New | +$209K |
|
|
ACB
772
Aurora Cannabis
ACB
$165M
| $180K | ﹤0.01% |
+192
| New | +$193K |
|
773
America Movil
AMX
$78.1B
| $180K | ﹤0.01% |
12,420
| – | – |
|
|
CHMA
774
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $175K | ﹤0.01% |
23,500
| – | – |
|
|
QCLS
775
Q/C Technologies Inc
QCLS
$25.4M
| $174K | ﹤0.01% |
3
| – | – |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2019 Portfolio in Review
As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
- Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
- Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
- Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
- Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
- Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
- Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.
Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.